In this panel discussion, Dr. Ikuo Hirano and Dr. Nirmala Gonsalves join the show to share details about a recent study published in the The New England Journal of Medicine that examined the use of a novel anti–Siglec-8 antibody known as AK002 for Eosinophilic Gastritis and Duodenitis.
